The IRBM Group is an revolutionary analysis and manufacturing group working throughout all points of drug discovery and early growth. 

Headquartered in Italy, IRBM fosters collaborations with organizations from the pharma, biotech, non-profit and educational sectors to speed up the event of vaccines and medicines. 

About 250 scientists work at IRBM’s R&D facility close to Rome, the place initiatives are carried out below one roof, enabling fast cycle instances and shut integration of the scientific groups. IRBM’s scientists have found a number of marketed therapeutics, and greater than 25 molecules have progressed into scientific testing.

We spoke with IRBM’s world vp of gross sales and advertising, Heidi Kingdon Jones, at Bio-Europe, which was held in Leipzig, Germany.

Source link